Anita Liberman

This inventor holds 20 USPTO granted patents and 1 published patent application, plus 2 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2002-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anita Liberman. Retrieved from https://idiyas.com/inventor/anita-liberman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 1)

% Patents Active = 35.0

CIPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 51(Granted Patents)

Location History:

Ramat Aviv, IL (2004)
Tel Aviv, IL (2002 - 2010)

Company Filing History:

20 out of 505

Teva Pharmaceutical Industries Limited

patents

Years Active: 2002-2010

Loading Chart...

Areas of Expertise:

Lansoprazole

Duloxetine

Sertraline

Benzimidazoles

Polymorphs

Crystallization

Purification

Synthesis

Impurities

Thiophene

Naphthol

Piperazine

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7842717 - DNT-maleate and methods of preparation thereof (2010-11-30),

2. 7759500 - 2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride (2010-07-20),

3. 7683177 - Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole (2010-03-23),

4. 7683080 - Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol (2010-03-23),

5. 7678816 - Method of stabilizing lansoprazole (2010-03-16),

6. 7622588 - Method for the purification of lansoprazole (2009-11-24),

7. 7534900 - Process for the purification of duloxetine hydrochloride (2009-05-19),

8. 7399871 - Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof (2008-07-15),

9. 7319171 - Sertraline hydrochloride form II and methods for the preparation thereof (2008-01-15),

10. 7196222 - Sertraline hydrochloride form II and methods for the preparation thereof (2007-03-27),

11. 7060837 - Method for the purification of lansoprazole (2006-06-13),

12. 7022881 - Sertraline hydrochloride polymorphs (2006-04-04),

13. 7022859 - Method for the purification of lansoprazole (2006-04-04),

14. 6909004 - Method for the purification of lansoprazole (2005-06-21),

15. 6723855 - Method for synthesizing leflunomide (2004-04-20),

Title: Inventor Spotlight: Anita Liberman - Pioneering Pharmaceutical Innovations

Introduction:

Anita Liberman, a distinguished inventor hailing from Tel Aviv, IL, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 20 patents. His relentless pursuit of innovation and dedication to advancing medical research have solidified his reputation as a trailblazer in the industry.

Latest Patents:

Among his latest patents is the groundbreaking 'DNT-maleate and methods of preparation thereof' - a novel compound and its polymorphs that hold immense promise in pharmaceutical formulations. Additionally, Liberman's invention of '2-(N-methyl-propanamine)-3-(2-naphthol)thiophene' as an impurity of duloxetine hydrochloride showcases his precision in identifying critical components for drug development.

Career Highlights:

Anita Liberman's exceptional talent and expertise are showcased through his affiliation with Teva Pharmaceutical Industries Limited, a renowned player in the pharmaceutical arena. His innovative spirit and strategic approach have propelled him to the forefront of drug discovery and development, earning him accolades within the company and the broader scientific community.

Collaborations:

In his pursuit of excellence, Anita Liberman has collaborated with esteemed colleagues such as Claude Singer and Tamar Nidam. Together, they have fostered a culture of innovation and collaboration, driving forward groundbreaking research initiatives that have the potential to revolutionize the pharmaceutical landscape.

Conclusion:

In conclusion, Anita Liberman stands as a testament to the power of ingenuity and perseverance in the realm of pharmaceutical innovation. His prolific career, marked by groundbreaking patents and strategic collaborations, underscores his status as a visionary inventor shaping the future of medical science.

Profile summary based on public USPTO records.